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Abstract 
Copy Number Variations (CNVs) are genomic structural variations frequently observed 
in healthy individuals, but can also lead to disease. They are the etiological cause of 
many rare genomic disorders that affect a large number of people in population, 
constituting a major public health problem. Unlike other small mutations, deleterious 
CNVs can reach millions of nucleotides containing several genes and other functional 
DNA regions. Many of these CNVs have yet unknown relationships to the phenotypes 
observed in patients. Therefore, the identification of the potentially affected molecular 
and genetical mechanisms in the CNVs and their relation with certain phenotypes in 
patients with rare deleterious disorders, nowadays, remains as a big challenge for 
clinical geneticists. Based on different datasets that links phenotypes, patients and 
genomic loci, two systemic approaches were used to understand the molecular basis 
that underlie those CNVs. Firstly, a functional analysis of the genes coded in these 
regions is carried out to realise which are the biological processes affected by the CNVs 
mutations thus to the phenotypes. Secondly, a network propagation analysis is done to 
expand the knowledge of the query genes and its interactome context. The results 
obtained for a cluster of patients and a number of phenotypes of clinical interest are 
briefly explained.  
 
Keywords: CNVs, phenotype, ontology, network, pathologies.  
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1. Introduction 
One of the main tasks of bioinformaticians is to develop and/or to combine existing 
computational methodologies in the pursuit of the understanding of the complex 
mutations that conform biodiversity. The mutation, as a concept, is poorly understood 
by society, so it has a negative connotation to those people unfamiliar with biological 
sciences. The term itself refers to a change that could have equally positive, negative or 
none effects at all. In any case they are largely determined by natural selection. 
 
In the context of this Master’s thesis, the mutations to be studied are DNA changes 
which seem to have unfavourable impacts in human population. These genomic 
alterations are of interest to the health system due to their relation with several 
different diseases. Although there are many types of mutations depending on how you 
classify them (Saitou, N. 2013)34, this work is focused on Copy Number Variations. They 
are a genomic structural variation involving the repetition of DNA segments ranging 
from one kilobase (kb) to several megabases (Clancy, S., 2008)10. CNVs are defined as 
pathological when the number of repetitions of the pattern segment diverge from a 
reference genome (Redon, R., et al., 2006)31. This variability can be classified into 
deletions, if the number of copies is lower compared with the reference genome, or 
duplications, if the number is higher, and like any other mutation CNVs are found in 
organisms by inheritance or spontaneous occurrence (de novo). Two examples of 
diseases where CNVs have an important role are fragile X syndrome (Lozano, R. et al., 
2014)19 and Huntington’s disease (Vittori, A. et al., 2014)45. 
 
It has been observed that the distribution of pathological CNVs length is significantly 
displaced towards higher values in relation to healthy population (Reyes-Palomares A. 
et al., 2016)32. Therefore, deleterious CNVs, unlike small mutations such as Single 
Nucleotide Polymorphisms (SNPs), can affect a larger number of genes and other 
functional DNA regions. Because of that, an intensified severity and complexity of the 
phenotypes is found on pathological CNVs, which makes still a challenge the 
identification of the actual genetic causes of the pathologies associated to this kind of 
mutation. It becomes even more difficult to set a reliable link between any specific CNV 
and a certain phenotype when large CNVs are usually related to a low prevalence in the 
population. 
  
In order to shed some light on pathological CNVs Dr. Ranea has created an undirected 
tripartite network that associates three entities: phenotypes, patients and “de novo” 
CNVs. This network has thousands of phenotype-patient-genotype associations 
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extracted from a dataset of patients with low prevalent genetic disorders included in 
the DECIPHER resource (DatabasE of genomiC varIation and Phenotype in Humans using 
Ensembl Resources - version of March 2016: approximately 17,000 patients, 24,000 
CNVs divided in 13,000 deletions and 11,000 duplications -) (Firth, H.V. et. al., 2009)11. 
These CNVs genotypes are worldwide collected and identified by microarray 
comparative analysis and other technologies, which have been demonstrated to be 
efficient techniques for the discovery of new chromosomal syndromes in many cases 
(Ballif BC. et al., 2007; Shaw-Smith C. et al., 2006)5, 37. Although the majority of rare 
genetic syndromes have a monogenic cause, phenotypes are associated to imbalances 
in different functionally related loci distributed along the genome. 
 
In view of the huge variability that all CNVs from DECIPHER might have, each CNV locus 
is defined as a small overlapping region (SOR) determined by the genomic regions 
shared among patients in the network. The phenotypes are defined according to the 
Human Phenotype Ontology (HPO) (Köhler et al., 2017)35. Since HPO is a hierarchical 
vocabulary, every term is expanded with its parents. Patients, who voluntarily provided 
informed consent, are totally anonymised and the majority is not diagnosed with a 
specific illness.  
 
A schematic representation of how is created the tripartite network is in Figure 1.  
 
 
 
Figure 1. Generation of a tripartite network using DECIPHER patient data. Circles represent phenotypes and rectangles 
loci. 1) Patients are phenotypically annotated using HPO terms; 2) A locus is generated as the chromosomal region 
where at least two patients CNVs with the same phenotype overlap; 3) The HPOs-patients subnetwork; 4) The 
patients-loci subnetwork; 5) The final tripartite network. 
 
The main purpose of the mentioned network is to find where the information converges 
regarding each type of edge in the network (e.g. CNV-loci to patients or phenotypes to 
patients). Therefore, if patients with different genomic disorders, pathological CNVs in 
our case, have the same phenotype we must look for common ground in their 
connection. 
Adrian Garcia Moreno - Master’s Thesis: From CNVs to Phenotypes 
6 
 
Chagoyen and Pazos showed that clinical signs, which are the phenotypes under study 
in this project, are reflected as modules at the molecular level to at least the same extent 
as diseases do (Chagoyen M. and Pazos F. 2016)9. The idea is that the biological 
processes and network modules associated to phenotypes or clusters of patients would 
provide a biological interpretation for the corresponding clinical signs or diseases, and 
eventually point to new disease markers or targets. 
 
In this master project we approach the study CNVs-loci relation to phenotypes from a 
systemic perspective. Firstly, we are going to check the biological processes enriched in 
the set of genes contained in the affected loci. Secondly, we will look for network 
modules where these genes tend to map. To this extent, the interpretation, in biological 
terms, of the relation between the genomic regions and 1) a given phenotype or 2) a 
cluster of patients with similar phenotypes is not trivial due to limitations of the methods 
mentioned above. 
2. Objectives 
1. Genomic annotation of all loci associated to each phenotype and cluster of 
patients. 
a. Division of loci in separate bed format files per phenotype and cluster. 
b. Genomic annotation using bedtools. 
c. Genes extraction. 
2. Functional annotation. 
a. Programmatic automation of Gene Ontology overrepresentation 
analysis. 
3. Network modules identification. 
4. Integration of the methodologies in a pipeline. 
5. Assessment of some results based on bibliographic sources. 
3. Materials and Methods 
 3.1. Initial Data 
Our starting point is the results obtained by the research group of Dr. Ranea. Seven 
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different datasets were obtained from the study of large-scale associations in the 
tripartite network described in the introduction (Perkins J., 2014; Reyes Palomares et 
al., 2013)29,32. These datasets are in the form of different collections of loci linked to 
phenotypes and to clusters of patients whose record of clinical signs in their clinical 
history has a certain degree of similarity. The datasets are divided in two groups 
regarding the two mentioned links of loci, four shows CNVs directly related to 
phenotypes and three are referred to clusters of patients. 
 
It is important to highlight that CNVs are annotated according to their mutation origin, 
which can be either by deletion or duplication. Some datasets gather the CNVs of a 
specific origin and their associated phenotypes according to the previous division. The 
reason for this division is that it is known that each kind of mutation in the same genomic 
region of the CNV could cause different effects. For example, in the 19p13.3 and 
19p13.13 syndromes, microdeletions lead to macrocephaly while microduplications 
cause microcephaly (Nevado et al., 2015; Dolan et al., 2010)28, 12, whereas in the region 
17p11.2, microdeletions lead to Smith-Magenis Syndrome and microduplications cause 
the Potocki-Lupski Syndrome. Even though these are just two examples there are many 
microdeletion-microduplication syndromes (Weise, A., et al., 2012)46.  
 
The relations between the phenotypes (HPO term) and the genomic regions are 
measured by a statistic-based index, the hypergeometric test (HyI). This index 
represents the log-transformed probability of observing an equal or greater number of 
shared nodes than expected by chance, and consequently measures the significance of 
the connections between the nodes in a directly proportional manner. Whilst the 
clusters of patients have been obtained using the Brainerd-Robinson coefficient, a 
similarity measure that was developed within archaeology, for comparing assemblages 
in terms of the proportions of types or other categorical data. This coefficient was 
calculated according to the phenotypical profiles of each patient once that the 
information content index of each HPO term has been obtained.  
 
In the first group of datasets (relationships HPO-loci) we found 4 different files: 1) where 
CNVs were “de novo” inherited, 2) CNVs that consist only in “de novo” deletions, 3) only 
“de novo” duplications, and 4) both “de novo” deletions and duplications. In a general 
oversight of the previous datasets altogether we find that 8575 CNVs loci are related to 
880 different phenotypes. Some CNVs have different HyI values for each linked HPO 
term, which led to 1158942 associations. The distribution of the HyI scores, ranging from 
0 to 18, is represented in Figure 2. 
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Figure 2. Representation of the number of loci within each HyI score range in every dataset.  
 
In the second group we found 3 datasets and, like in the previous group, they classify 
the “de novo” CNVs by duplications, deletions and both mixed. The files contain 4230 
unique CNV loci distributed in 14227 different clusters of patients with similar clinical 
signs, which gives back 421496 loci-cluster associations. A cluster could be understood 
as a syndrome or disease where loci of patients with similar phenotypic profiles are 
gathered. Despite the previous interpretation, it might be difficult to acknowledge that 
we have that many syndromes information. That is because these clusters are not 
independent but form a hierarchical structure, where a given cluster could be entirely 
or partially enclosed in a larger one.  
 
The CNVs in these last datasets are associated, besides to their mutation origin, to a 
score that follows the DECIPHER’s pathogenicity classification system. Since we are 
aware of microdeletion/microduplication syndromes, we must consider the unique loci 
and its duplication and deletion variants, what provide us with 4266 variants. There are 
34 of these variants excluded from the following chart, Figure 3, because they have more 
than one different pathogenicity grade annotated. The motive of this disagreement can 
be explained due to the fact that researchers do not come to the same conclusions, and 
its reflected in the notorious percentages of unknown and uncertain consequences. 
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Figure 3. Distribution of CNV variants according to their pathogenicity. Left: Proportional distribution of the 4232 
different variants. Around 58% of the CNVs have consequences not yet known and 9% its suspected. Right: 
Quantitative distribution of variants of each clusters dataset (from inside to outside: first CNVs with duplications, 
secondly deletions, and thirdly both).   
 3.2. Genomic Annotation 
Each CNV could contain various genomic elements but we are interested in retrieving all 
the genes that overlap with our genomic regions in at least one base-pair. This can be 
done using the software of Bedtools (Quinlan AR. and Hall IM, 2010)30 along with a 
proper annotation file and the datasets described in the previous point once 
transformed into bed format. 
 
The genomic regions retrieved from DECIPHER are given in terms of the Genome 
Reference Consortium Human Build 37 (GRCh37), also known as hg19. We recognise 
that this assembly is not the most recent, GRCh38, and although there are tools to 
transform the loci coordinates into the current assembly, we decided not to transform 
our initial data to avoid possible confusions. In this scenario we used the latest hg19 
annotation file (in GFF3 format) downloaded from the file transfer protocol (ftp) site of 
the National Centre for Biotechnology Information (NCBI). The main advantage of using 
the files from these sites is that they are often updated daily and with a small script it 
would be possible to download and use the latest annotation and the software that 
needs them in a single command. The downside is that the data in this files might not 
be enough curated for certain types of studies.  
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Prior to the annotation, each dataset is divided into different subsets, each containing 
all the loci that correspond to a specific HPO term or cluster of patients so that we can 
study all the phenotypes or clusters individually. Additionally, the loci associated directly 
to HPOs were split with different HyI scores cut-offs, ranging from 2 to 5 in steps of 0.5. 
We ended up with four datasets broken down in seven restrictive HyI scores and three 
clusters datasets.  
 
Finally, Bedtools will help us to annotate everything included in the genomic regions and 
with the design of a small script we are able to extract the genes included in the loci of 
each phenotype and cluster. 
 3.3. Functional Annotation 
There are two types of analysis when a functional annotation is performed that should 
be differentiated. Sometimes the query genes might have quantitative associated 
values, for example to indicate differential expression or just a rank used to prioritise 
them. In this case we will be carrying out an enrichment analysis. However, if no gene-
wise scores are provided, this analysis should be called a functional overrepresentation 
and it is the one pertinent to our data. The overrepresentation analysis reports the 
biological processes where our query genes have greater presence, not being possible 
to differentiate the effect of genes in those processes unlike the enrichment analysis. 
 
In this project, the Gene Ontology (GO) database is chosen as the source of terms that 
reflects functional units (Ashburner et al., 2000; The Gene Ontology Consortium. 
2017)4,40. Even though, there are three categories of Gene Ontology, we used the 
following two: cellular component and biological process. The molecular function 
ontology was ruled out because it does not reflect the functional information related to 
biological systems we are interested in. 
 
We need to find out which are these processes and cellular compartments for each gene 
list, that there are as many as different clusters and phenotypes we have annotated in 
the previous point. It also could be found that the same phenotype appears in different 
datasets, as it is shown in Figure 4, which is a reason for the huge number of genes lists. 
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Figure 4. Venn diagram showing the phenotypes distribution across the initial datasets. 
 
Once we take into consideration the amount of data that is being handled, the use of a 
non-programmatic tool to do the analysis is discarded. It was difficult to find a proper 
tool that is not either a web service or one based in a user interface. Nevertheless, after 
a comparative search It was decided to employ the topGO R package because it is 
constantly maintained and widely used by scientific community (Alexa, A. and 
Rahnenfuhrer, J. 2016)². 
 
A GO overrepresentation analysis is based on gene counts. Tests like Fisher’s exact test, 
hypergeometric test and binomial test can be used for that (Draghici, S. et al., 2006)¹³. 
TopGO offers the possibility to choose between these and other kind of predefined 
statistical tests while could also be user-defined. In our case we opted for the Fisher's 
exact test.  
 
TopGO needs a gene to GO identifier map file, which can be found on some annotation 
databases of R packages but is preferable to create a new one. To achieve this, I used 
the gene to GO annotation file found in the gene data folder at the NCBI ftp site. Like 
the GFF3 file commented earlier, this one is re-calculated daily and, in a short R script, 
its download, transformation to a mapping file and subsequent use, could be included, 
along with the overrepresentation analysis workflow. 
 3.4. Network Modules 
In systems biology there is a technique, widely used in other professional sectors such 
as law enforcement and marketing, that is growing in importance called network 
propagation. It is a link analysis algorithm that explores the relations of the nodes in a 
network, which in bioinformatics it normally represents an interactome of genes and/or 
proteins, but could also represent any other molecular phenomena in terms of entities 
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and relationships. This algorithm could be implemented in two ways. The first 
implementation is known by several names: PageRank, the random surfer model or 
random walk with restart. The second is called heat diffusion and it is the one used in 
our last approach in the study, because this algorithm has shown computational 
advantages, especially for bigger networks and queries, in comparison with the others 
(Al-Mohy et al., 2011)1. 
 
Like its own name indicates the heat diffusion algorithm considers the network as a 
closed conductive medium in which an input heat, determined by the sum of that 
assigned in the query nodes, diffuses through it. The diffusion happens until a certain 
time is reached, if time would tend to infinite then heat will be uniformly distributed in 
the network. At that time, each node will have a specific value of heat associated. Those 
with highest values are the ones in closest relationship to the query set.  
 
The heat diffusion algorithm that is going to be used is implemented by Carlin et al 
(Carlin, DE. et al., 2017)⁷ and all its details can be found in their publication. Interestingly, 
they showed that the Spearman correlation, between adjacent time steps for various 
network sizes and the same for a fixed network of 10.000 nodes with various 
proportions of the graph included in the query, is stronger with time close to 0.1. This 
means that heat distribution is similar regardless the number of nodes in the network 
and the query set when this time is used, so it is the default value for their algorithm 
although it could be personalised. 
 
This algorithm has been implemented in Cytoscape 3.6 and could be installed for 
previous versions searching in the apps by its name, Diffusion. But its usage is not 
dependent on Cytoscape, which means, its developers freed the code on Github so that 
it can be used programmatically outside Cytoscape. Diffusion is callable via a REST-base 
Application Programming interface (API) in order to offer the possibility of being used in 
several programming languages and via cURL. However, it is recommended to rely on 
Python because the network, with an initial heat amount assigned to the query nodes, 
must reach the service in CX json format and the main library to handle this format, 
Networkx, is in that language. This powerful library also offers the opportunity to use 
the service massively and retrieve the results according to our own criteria.  
 
The network used for this analysis is the latest version of the human interactome in 
Biogrid (Stark, C. et al., 2006)38 merged with the network generated by Menche 
combining different resources (Menche, J. et al., 2015)24. This final network has 17253 
genes and 335635 edges. 
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3.5. Pipeline 
Once all methodologies are in place, they were integrated into a single pipeline. The 
actual implementation let the user choose a certain threshold score (HyI in our case) to 
filter the loci of the initial bed file. After that, loci are grouped together in individual bed 
files regarding each relation of them with the associated feature (phenotype/patients 
cluster in the context of our data). The next step is to retrieve the genomic elements 
annotation using bedtools systematically. As we are interested on coding elements, from 
that annotation we take the genes in individual lists attending to the previous division. 
Optionally, the genes could be associated with the score of the genomic loci. These 
genes lists could continue in two different ways. The first one, already implemented, is 
the GO overrepresentation analysis whereas the second choice, which is still not 
integrated in the pipeline, is the network propagation analysis with heat diffusion 
algorithm.  
 
The GO overrepresentation analysis uses a default p-value cut-off of 0.05 but any other 
value could be provided. It also uses the three ontologies (Cellular Compartment, 
Molecular Function and Biological Process) as default but the user could choose those 
of interest.  
 
The results are then merged into a single summary file which shows the genes below 
their original genomic region and the different results of the functional 
overrepresentation in individual tables of the chosen GO categories. A second p-value 
threshold could be chosen to filter again the results. Finally, this file is formatted into a 
html (Hypertext Markup Language) to facilitate its inspection as well as including links 
to additional data and websites: HPO pages, NCBI genes pages, the loci visualisation in 
the UCSC (University of California, Santa Cruz) genome browser in the hg19 assembly, 
files with the significant genes, generated during the overrepresentation analysis, and 
the graphic representation of the significant biological processes in the GO network by 
TopGO and AmiGO.  
 
The different steps of the pipeline can be started at any point and it allows the user to 
give as an input a folder with the initial query files or a single file. All the scripts that 
conforms the workflow and the pipeline itself are handled with command-line 
arguments when a principal script is invoked. 
 
The whole pipeline was made freely available at GitHub, as python and R scripts: 
https://github.com/EidrianGM/FromBed2NetPipeLine  
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A schematic representation of the pipeline, in the context of this Master's thesis is given 
in Figure 5.  
 
 
Figure 5. From any bed file that associates loci to different features, its genes are extracted individually for each one. 
Then a functional annotation and network propagation analysis is carried out with the genes of every feature. 
4. Results and Discussion 
To begin with, we must count the number of clusters and phenotypes whose most 
significant GO biological process is associated at a certain p-value, it should be noted 
that TopGO returns a maximum of 10E-30. This count is done for each dataset and it is 
shown in Figure 6 and 7 which can be used to select a p-value cut-off separating the 
most interesting cluster-GO and HPO-GO associations for further study.  
 
Figure 6. Number of clusters whose most significant biological process falls into a certain level of significance (-log(p-
value)) from 2 to 30, left to right, in each dataset. Surprisingly and in contraposition with the phenotypes results we 
find more clusters than expected for the highest value of GO terms significance. 
Dup + Del Clusters 
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Figure 7. Number of phenotypes whose most significant biological process falls into a certain level of significance (-
log(p-value)) from 0 to above 6 in each dataset. In the legend it is displayed the different HyI cut-offs in our initial 
datasets. As it is expectable the number of phenotypes decrease with higher HyI and GO terms p-values.  
 
It seems reasonable to start studying the results from the loci with an HyI score above 
4. For both, clusters and phenotypes, the minimum p-value of their most enriched 
biological process should be 0.001.  
 
As it shown in Figure 8, thanks to the html summary report of the results is easier to 
expand the information associated with a certain phenotype thus making it easier to 
understand its molecular implications. 
 
  
Figure 8. Screenshot of summary of results in html format. 
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Some of the results are really interesting because they inform about biological processes 
that are already known to be related with certain phenotypes, thus allowing us to 
suppose that these CNVs might be a cause. This can be seen in the following phenotypes, 
microcephaly (HP:0000252), small nail (HP:0001792), cerebellar hypoplasia 
(HP:0001321), general myoclonic seizures (HP:0002123), proportionate short stature 
(HP:0003508), hyperactivity (HP:0000752). The first three mentioned clinical signs, have 
CNVs loci with HyI score above 5, conversely, the HyI score of the other phenotypes is 
lower than 5 but greater than 4. In the following paragraphs some aspects of these 
results are addressed. 
4.1. Microcephaly  
Microcephaly is the condition where the head is significantly smaller than the average. 
In the duplications CNVs, results showed that only GO processes related with box H/ACA 
snoRNA are reported as significant thanks to the presence of DKC1. This gene is related 
to dyskeratosis congenita, a multisystem disorder caused by defective telomere 
maintenance. Some of the patients suffering this disorder, described in Marrone et al. 
had microcephaly associated (Marrone, A, et al., 2007)²². In the deletions CNVs dataset, 
while lithium ion related processes where issued, in the dataset with loci with both 
deletions and duplications, mainly iron and copper transportation processes are 
reported. However, the loci associated to microcephaly, in both mentioned datasets, 
enclosed genes that result in enriched processes related chorion and pancreas 
development. CDK6, one of the genes involved in pancreas development, is within a CNV 
locus associated to the phenotype in question (Muhammad S. et al, 2013)26. 
4.2. Small Nail 
The nail is a plate-like, keratinous, translucent structure that consists of highly 
specialised epithelial cells, called keratinocytes, that grows from a deep groove in the 
dermis of the skin. Above the layer of keratinocytes, we find the cornified envelope, 
composed by several layers of terminally differentiated, dead keratinocytes (Candi et 
al., 2016)6. As it could be expected, the three most significantly biological processes, 
reported by the loci linked to small nail phenotype, are keratinisation, keratinocytes 
differentiation, and cornification. On the one hand, several keratins of type II (KRTs 1, 2, 
3, 4, 8, 73, 77, 78, 79) and type I (KRT18) among other genes are coded in the 
corresponding loci. On the other hand, many homeobox genes (HOXC 4, 5, 6, 9, 11, 12, 
13) are also encoded in this loci and HOXC13 is known to have a direct impact in nails 
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and hair development (Lin, Z. et al., 2012; Li, X. et al., 2017)18,16. 
4.3. Cerebellar Hypoplasia 
Cerebellar hypoplasia is the term used to illustrate the underdevelopment of the 
cerebellum. The CNVs that are related to this phenotype have a specific locus that 
includes two monoamine oxidases, MAOA and MAOB. Alternatively, a larger number of 
loci contain the gene CASK, a calcium/calmodulin dependent serine protein kinase. The 
presence of these genes reported as significant biological processes those associated 
with neurotransmitters catabolism in general, and catecholamines in particular, 
specially dopamine. The association between MAOA and the phenotype has been 
reported by Alzghoul et al. in mice (Alzghoul, L. et al., 2012)3. On the other hand, all 
patients under study by Naijm et al. have mutations of CASK and showed cerebellar 
hypoplasia (Naijm et al., 2008)27. Moreover, we find the Norrie disease pseudoglioma 
gene (NDP) which was extensively studied in its relation with cerebellum development 
(Tokarew, N, 2017)43. 
 
Only the previous mentioned genes are included in our network, thus they will be the 
initial heat diffusion nodes. After doing the network propagation analysis we find three 
of the previous genes in two separated modules with the top heated nodes applying a 
cut-off at 0.01. The heat distribution is reflected in Figure 9.  
Figure 9. Heat distribution results after the diffusion from the genes within the loci associated to Cerebellar 
hypoplasia. Heat amount is represented as a decreasing gradient from red to light red. 
 
NDP is the most heated node and its paired with FZD4, one of the two receptors of the 
product of NDP, norrin protein. Norrin/Frizzled4 signaling activates the canonical Wnt 
pathway to control retinal vascular development. Using genetically engineered mice, it 
was found that in the adult retina and cerebellum, gain or loss of Norrin/Fz4 signaling 
results in a cell-autonomous gain or loss, respectively, of blood retina barrier (BRB) and 
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blood brain barrier (BBB) function, indicating an ongoing requirement for Frizzled 
signaling in barrier maintenance and substantial plasticity in mature CNS vascular 
structure (Ye, X. et al., 2010)47. 
 
The monoamine oxidases are in a bigger module with several alcohol and aldehyde 
dehydrogenases (ADHs and ALDHs), decarboxylases of ornithine, dopa and histidine, 
and other amine oxidases. In general, and according to KEGG functional annotation 
these genes are related with tyrosine, retinol, histidine, phenylalanine and cytochrome 
P450 drug metabolism. 
4.4. General Myoclonic Seizures  
General myoclonic seizures are brief, shock-like jerks of a muscle or a group of muscles 
that usually do not last more than a second or two but could happen in sequence within 
a short time. To some degree, it may occur occasionally to otherwise healthy people, for 
instance, hiccups may be considered a type of myoclonus. Nonetheless, this clinical sign 
is mainly found in epilepsy, the fourth most common neurological disorder in human 
population, but also in multiple sclerosis, Parkinson's disease, Alzheimer's disease, or 
Creutzfeldt-Jakob disease. As a result of studying the loci associated to the phenotype 
in question, there are three genes frequently associated in literature with epilepsy, 
SCN1A, SCN2A, SCN9A (Meisler et al.,2005; Catterall 2012; Zhou et al., 2018)23, 8, 48. The 
product of these genes are 3 subunits of voltage-gated sodium channels whose function 
is the generation and propagation of action potentials in neurones and muscle.  
 
The only genes in the loci associated to general myoclonic seizures that are present in 
our network are the genes SCN1A, SCN2A, TTC21B and GALNT3. The modules found 
when applying the previous mention cut-off are shown in Figure 10. 
 
 
Figure 10. Network modules associated to general myoclonic seizures. Heat amount is represented as a decreasing 
gradient from red to white. 
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The module of SCN2A gathers another sodium channel gene, SCN4B. ANK3 is found at 
the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral 
nervous systems and play a key role in activities such as cell motility, activation, 
proliferation, contact, and the maintenance of specialised membrane domains. 
ARHGEF10L belongs to the RhoGEF subfamily of RhoGTPases which are activated by 
specific guanine nucleotide exchange factors (GEFs) and are involved in signal 
transduction. The expression of RNF130 in the mouse counterpart was found to be 
upregulated in myeloblastic cells following IL3 deprivation, suggesting that this gene 
may regulate growth factor withdrawal-induced apoptosis of myeloid precursor cells. 
MPP3 gene product is a member of a family of membrane-associated proteins termed 
MAGUKs (membrane-associated guanylate kinase homologs). MAGUKs interact with the 
cytoskeleton and regulate cell proliferation, signaling pathways, and intracellular 
junctions. This protein contains a conserved sequence, called the SH3 (src homology 3) 
motif, found in several other proteins that associate with the cytoskeleton and are 
suspected to play important roles in signal transduction. 
 
The other two most heated nodes are GALNT3 and TTC21B distributed in two separated 
modules. These genes were found mutated in people suffering from Dravet syndrome, 
an epileptic encephalopathy using array comparative genomic hybridisation (Marini et 
al.,2009)21 where it was confirmed also deletion mutations in SCN1A. However these 
genes are relatively closed to it and its deletions has been demonstrated that sometimes 
affects to as many as 20 additional genes (Madia et al., 2006; Suls et al., 2006)20,39. 
4.5. Proportionate Short Stature 
The next phenotype, proportionate short stature, has associated loci whose genes 
produce an enrichment in biological processes related with the embryo development. A 
visual summary of the results is displayed in Figure 11, with a word-cloud plot. 
 
 
 
Figure 11. The significance of the biological processes associated with proportionate short stature.  
 
The explanation for this functional annotation results is that one of the CNVs loci 
(chr7:26613851:28749226) covers the homeobox cluster A genes 1, 2, 3, 5, 6, 7, 9, 10 
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and 11. This homeobox genes encode DNA-binding transcription factors that may 
regulate gene expression, morphogenesis, and differentiation during embryonic 
development. Other genes that spanned in the CNVs loci of the short stature phenotype 
are CHSY1 and ADAMTS17, and they have been directly associated to it in several articles 
(Khan et al., 2012; Li et al., 2010; Morales et al., 2009; Van Duyvenvoorde et al., 2014)15,17, 25 ,44. 
4.6. Hyperactivity 
Hyperactivity is normally attributed to children, but in MedLinePlus, the hyperactive 
person is defined as that “with increased movement, impulsive actions, and being easily 
distracted”. When it is about children, hyperactivity is often considered more of a 
problem for schools and parents than it is for themselves. Notwithstanding, many 
hyperactive children are unhappy, or even depressed because of their different social 
rhythm. The loci that we found directly associated with to this phenotype contain genes 
of interleukin receptors and sodium channels genes. The mentioned receptors are 
interleukin 1 type 1 (IL1R1), 2 (IL1R2) and like 2 (IL1RL2) along with receptor 1 and its 
accessory protein gene for interleukin 18 (ILR18R1 and IL18RAP). For example, Segman 
et al. (2002) informs about a possible association between IL1R1 and Attention deficit 
hyperactivity disorder (Segman et al. 2002)36. Links between sodium (e.g. in food 
additives) and hyperactivity have also been reported (Kemp, A. 2008)14. 
4.7. Cluster Of Patients 
Lastly, an example of a cluster of patients in the duplication dataset, whose most 
significant biological processes are very different between them. As the reader could 
see in the Figure 12, processes associated to glutathione metabolism, leukotriene 
biosynthesis, regulation of sprouting angiogenesis, behavior and sulfur metabolism are 
among the most significant in this cluster. 
 
 
 
Figure 12. The significance of the processes associated with the cluster in question.  
 
After a bibliographic search of this processes a possible syndrome related with these 
results is the Ethylmalonic Encephalopathy. This disorder affects several body systems, 
particularly the nervous system. Neurological signs and symptoms include delay and 
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regression in development, weak muscle tone (hypotonia), seizures, and abnormal 
movements. The body network of blood vessels (the vascular system) is also affected. It 
is a mitochondrial disorder caused by genetic abnormalities of sulfide metabolism 
whose main trigger mutation is on gene ETHE1 (Tiranti et al., 2006; Tiranti et al., 2013)41, 42. 
ETHE1 is a sulfur dioxygenase that plays an essential role in hydrogen sulfide catabolism 
in the mitochondrial matrix. However, this gene is not reported in the sulfur related GO 
terms. Despite the similarity of the disorder signs and the biological processes enriched 
in this cluster it is very difficult to explain what is behind a cluster without further 
analysis. 
 4.8. Actual Knowledge 
The Human Phenotype Ontology offers a curated annotation file where each phenotype 
is linked to specific genes. The links are generated using the information about the 
phenotypes of a particular syndrome and the corresponding genes that are known to 
cause this syndrome when mutated. The syndromes information comes from OMIM and 
ORPHANET. The links between genes and phenotypes are offered in two different 
annotation files, all genes associated or only frequently associated. To compare the gene 
lists derived from our phenotype-related CNVs and those annotated we used the file 
that gathers all the genes with known association. In the following table we find the 
number of phenotype gene lists that have only known genes, with some known and 
without known for every gene list obtained and for each CNVs-loci HyI score cut-off.  
 
Dataset 
HyI Score 
Cut-off 
Without 
Known Genes 
With Some Known 
Genes 
With Only 
Known Genes 
Deletions 
2 
225 577 0 
Duplications 121 309 0 
Dup + Del 250 630 0 
“De Novo” 144 209 5 
Deletions 
2.5 
260 538 1 
Duplications 173 250 1 
Dup + Del 288 590 2 
“De Novo” 164 189 5 
Deletions 
3 
303 494 1 
Duplications 213 191 2 
Dup + Del 338 537 1 
“De Novo” 185 166 6 
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Deletions 
3.5 
333 441 1 
Duplications 214 131 2 
Dup + Del 389 447 5 
“De Novo” 202 138 6 
Deletions 
4 
352 364 6 
Duplications 190 77 1 
Dup + Del 402 351 6 
“De Novo” 192 110 8 
Deletions 
4.5 
 
296 297 6 
Duplications 129 46 1 
Dup + Del 335 278 8 
“De Novo” 159 82 9 
Deletions 
5 
217 238 6 
Duplications 58 21 0 
Dup + Del 241 224 4 
“De Novo” 111 66 8 
 
Table 1. It shows the number of phenotypes that when compared its genes, extracted from the loci of each dataset 
and for every HyI cut-off, with those from the actual knowledge, have all, some or none genes in common. As it can 
be seen the number of phenotypes with all its genes in common grows for more restrictive values of HyI until the 4.5 
value, what implies that the study of the initial network weight properly the loci.  
5. Conclusions 
The approach used in this project is an instance of an integrating study. Firstly, because 
we are able to find already known genetic causes of the phenotypes in our CNVs and 
secondly because most of the patients under study were not diagnosed with a specific 
syndrome and now, in both cases, we are able to propose new candidate genes in 
addition to classify patients with different syndromes. 
 
On the one hand, the functional annotation of all the genes of a certain phenotype or 
cluster of patients allows us to identify the biological process or processes mutated 
which are a probable cause of the disorder. After a bibliography search we can 
corroborate, with empirical evidence, that some of the genes annotated in a certain 
enriched process are, or are suspected to be, linked with the phenotype. The fact that 
we find the same associations is a suggestion that our methodology is in the good way. 
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On the other hand, the network propagation analysis expands the context of the genes 
to the molecular interactome. It is expected that the query genes of a significant process 
are gathered in different modules where each one is among the top heated in the 
diffused network. In the resulting modules, new genes with strong relation to our query 
could be identified whose inclusion opens a new path of further study because there is 
little or no direct evidence of involvement with the human phenotype. However, this 
methodology depends on the network used and the query genes itself. In our case, we 
found that the network does not always contained all the genes associated to each 
phenotype or cluster, or the number of query genes was too high to find evident 
modules. 
 
In both cases, detecting the GO biological process or the network module associated to 
a given phenotype allows to 1) put that phenotype into a molecular context, and 2) find 
other genes (not in the original loci) that could serve as new markers or even drug 
targets for that phenotype. It should be taken into account that these phenotypes are 
associated to patients who are undiagnosed. 
 
With regards to perform this kind of analysis in in future research works, the pipeline 
will be continuously improved to face any issue and add new features. However, a 
difficulty is derived from the network propagation analysis given that it is difficult to set 
an arbitrary cut-off to select a certain number of top heated nodes. A study that tries to 
find the relation between the number of the query nodes, its topological features and 
those of the network could bring in new and original results. 
 
It has been also proposed to do a clustering analysis of the phenotypes using its related 
genes as categorical features. In a first attempt we used Graphext, a private tool that 
offers personalised clustering services. The gene profile of each phenotype are joined in 
a matrix which, due to the high variability that our datasets have, must be transformed 
using a Principal Component Analysis (PCA). The resulting matrix is then uploaded to 
Graphext whose algorithm calculates the distance between each pair of similar arrays, 
the gene profiles of each phenotype in our case. Then a network is drawn with those 
pair of vectors in profuse force layout. Finally, the clusters are identified as communities 
using Louvain Methodology. The results are shown in Figure 13. 
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Figure 13. Clustering of genotypic profiles of each phenotype for the dataset of “de novo” with loci of HyI index above 
4 associated. 
 
Exploring this clustering analysis could offer interesting conclusions about the 
comorbidity of the phenotypes, because if they share a significant number of mutated 
genes it could be expected that the phenotypes appears in a patient altogether. 
 
Another future prospect is try to devise a way of automatically analyse all the GO-HPO 
and GO-cluster associations that have been found (thousands). For this master project, 
only a qualitative discussion of some interesting cases was feasible. Such large scale 
analysis could involve text-mining of the literature.  
 
Finally, a more ambitious future sequel of this study would involve analysing other 
genomic elements present in the loci, besides the coding genes. Such analysis, involving, 
among other things, epigenetic information, would point to other possible molecular 
mechanisms not directly reflected in the gene repertories. 
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